Benjamin Nisman
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Reproductive Medicine top 5%
- Ovarian function and disorders
Papers in
- Oncology 15
- Lung Cancer Research Studies 8
-
- Lung Cancer Treatments and Mutations 5
- Advanced Breast Cancer Therapies 2
- Co-authors
- Vivian Barak (16 shared papers)Tamar Peretz (27 shared papers)V. Barak (5 shared papers)Yoram Abramov (2 shared papers)Norman Heching (6 shared papers)Joseph G. Schenker (1 shared paper)Inna Kalickman (2 shared papers)Dov Pode (5 shared papers)
In The Last Decade
Benjamin Nisman
43 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Biological Psychiatry 76
- Reproductive Medicine 203
- Oncology 285
- Cell Biology 167
- Behavioral Neuroscience 33
Countries citing papers authored by Benjamin Nisman
This map shows the geographic impact of Benjamin Nisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Nisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Nisman more than expected).
Fields of papers citing papers by Benjamin Nisman
This network shows the impact of papers produced by Benjamin Nisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Nisman. The network helps show where Benjamin Nisman may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Nisman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytokines in Gaucher's disease. | 1999 | 154 |
| 2 | 1997 | 150 | |
| 3 | 1998 | 138 | |
| 4 | 1996 | 98 | |
| 5 | 1998 | 93 | |
| 6 | 1995 | 82 | |
| 7 | 2006 | 73 | |
| 8 | 2002 | 64 | |
| 9 | 1995 | 60 | |
| 10 | The diagnostic and prognostic value of ProGRP in lung cancer. | 2009 | 58 |
| 11 | Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. | 2000 | 40 |
| 12 | 2010 | 35 | |
| 13 | 2012 | 31 | |
| 14 | 2008 | 31 | |
| 15 | 2005 | 31 | |
| 16 | 1998 | 30 | |
| 17 | 2010 | 28 | |
| 18 | 2007 | 26 | |
| 19 | 2010 | 23 | |
| 20 | 2014 | 22 |
About Benjamin Nisman
Benjamin Nisman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Immunology, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Treatments and Mutations (5 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Ovarian function and disorders (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Biological Psychiatry (76 citations), Reproductive Medicine (203 citations), Oncology (285 citations), Cell Biology (167 citations) and Behavioral Neuroscience (33 citations). Benjamin Nisman has collaborated with scholars based in Israel, Sweden and Germany. Frequent co-authors include Vivian Barak, Tamar Peretz, V. Barak, Yoram Abramov, Norman Heching, Joseph G. Schenker, Inna Kalickman, Dov Pode, Haim Biran and I. Kalickman. Their work appears in journals such as Anticancer Research, British Journal of Cancer, Cancer Biomarkers, Journal of Thoracic Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.